News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
FLOWERS KIRSTEN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| FLOWERS KIRSTEN (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 21,500 options to buy
@ $5.59, valued at
$120.2k
|
|
| 05/16/2023 |
4
| FLOWERS KIRSTEN (Director) has filed a Form 4 on Comera Life Sciences Holdings, Inc.|
Txns:
| Granted 39,491 options to buy
@ $0.69, valued at
$27.2k
|
|
| 02/14/2023 |
4/A
| FLOWERS KIRSTEN (Director) has filed a Form 4 on Comera Life Sciences Holdings, Inc.|
Txns:
| Bought 13,513 shares
@ $1.23, valued at
$16.6k
Bought 13,513 warrants
@ $0.25, valued at
$3.4k
|
|
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2023 |
4
| FLOWERS KIRSTEN (Director) has filed a Form 4 on Comera Life Sciences Holdings, Inc.|
Txns:
| Granted 13,513 shares
@ $1.23, valued at
$16.6k
Granted 13,513 warrants
@ $0.25, valued at
$3.4k
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/28/2022 |
4
| FLOWERS KIRSTEN (Chief Commercial Officer) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 21,900 shares
@ $0
Granted 171,000 options to buy
@ $14.15, valued at
$2.4M
|
|
| 01/10/2022 |
4
| FLOWERS KIRSTEN (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Exercised 32,677 options to buy
@ $19.06, valued at
$622.8k
|
|
| 01/10/2022 |
3
| FLOWERS KIRSTEN (Director) has filed a Form 3 on PMV Pharmaceuticals, Inc. |
| 01/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2020 |
4
| FLOWERS KIRSTEN (Chief Commercial Officer) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 250,000 options to buy
@ $13.85, valued at
$3.5M
|
|
| 01/07/2020 |
3
| FLOWERS KIRSTEN (Chief Commercial Officer) has filed a Form 3 on Kura Oncology, Inc. |
|
|